Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian

Deutsche Bank Analyst Sees Much Growth Ahead For FedEx


In a report published Monday, Deutsche Bank analyst Robert Salmon raised the price target on FedEx Corporation (NYSE: FDX) from $209 to $216. He also adjusted his EPS estimate from $9.00 to $9.65. Salmon reiterated a Buy rating on the company.

Upside for 4Q15

Salmon expects a positive report from FedEx executives as they release their fourth quarter earnings this Wednesday as well as an upbeat outlook for 2016. He cites "tailwinds from its profit improvement plan, secular e-commerce growth, and competitor pricing initiatives" as reasons for optimism.

He is modeling fourth quarter EPS of $2.90, significantly above consensus estimates of $2.68.

Salmon's bullishness is encouraged both by what he sees as both industry growth and firm growth.

Company-Specific Growth

Salmon says that FedEx is "in the midst of a multi-year company-specific growth story." He expects the shipping firm to benefit substantially from its profit improvement plan as well as revenue synergies with GENCO, a logistics-services provider that FDX acquired earlier this year.

He thinks investor confidence will soar based on the profit improvement strategy soon, as the company is expected to kickstart "75 percent of the $1.6 billion dollar initiative as it exits this quarter." The full benefit of the plan is expected to be felt in FY17.

As for GENCO, Salmon suggests that it could be helpful in "encouraging customers to direct meaningful small package volumes to FedEx Ground."

Salmon also predicts significant revenue boosts from a proposed acquisition of TNT Express (AMS: TNTE), which he sees as the third leg of the growth story. He says the acquisition would greatly increase FedEx's European exposure by giving it a pan-European ground network.

Despite the positive Deutsche Bank report, FDX's stock was trading down about 0.5 percent shortly after its release.

Latest Ratings for FDX

Apr 2019DowngradesNeutralSell
Apr 2019DowngradesBuyHold
Mar 2019DowngradesPositiveNeutral

View More Analyst Ratings for FDX
View the Latest Analyst Ratings

Posted-In: FedEx Corp. GENCO Robert SalmonAnalyst Color Reiteration Analyst Ratings


Related Articles (FDX)

View Comments and Join the Discussion!

Latest Ratings

GRUBInitiates Coverage On
HOTHInitiates Coverage On
NDRAInitiates Coverage On
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Aerie Pharmaceuticals Receives Positive Feedback from FDA

Avalanche Biotechnologies, Inc. Announces Positive Top-Line Phase 2a Results for AVA-101 in Wet Age-Related Macular Degeneration